European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - dibotermin alfa - bone morphogenetic proteins - dogs - osteoinductive agent for use in the treatment of long-bone fractures as an adjunct to standard surgical care using open fracture reduction in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - meloxicam - oxicams - dogs - alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - inactivated west nile virus, strain vm-2 - immunologicals for equidae - horses - for the active immunisation of horses of six months of age or older against west-nile-virus disease by reducing the number of viraemic horses.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - dirlotapide - antiobesity preparations, excl. diet products - dogs - as an aid in the management of overweight and obesity in adult dogs. to be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - tulathromycin - antibacterials for systemic use - pigs; cattle; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis sensitive to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. draxxin should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - oclacitinib maleate - agents for dermatitis, excluding corticosteroids - dogs - - treatment of pruritus associated with allergic dermatitis in dogs.- treatment of clinical manifestations of atopic dermatitis in dogs.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - ceftiofur - antibacterials for systemic use - pigs; cattle - pigstreatment of bacterial respiratory disease associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and streptococcus suis.treatment of septicaemia, polyarthritis or polyserositis associated with streptococcus suis infection.cattletreatment of acute interdigital necrobacillosis in cattle also known as panaritium or foot rot.treatment of acute post-partum (puerperal) metritis in cattle, in cases where treatment with another antimicrobial has failed.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - frunevetmab - analgesics - cats - for the alleviation of pain associated with osteoarthritis in cats.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - horses; pigs; cattle - cattlefor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs. for use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy. for the relief of post-operative pain following dehorning in calves.pigsfor the reduction of symptoms of lameness and inflammation in non-infectious locomotor disorders and for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.horsesfor use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders. for the relief of pain associated with equine colic.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - pirlimycin - antibacterials for intramammary use - cattle - for the treatment of subclinical mastitis in lactating cows due to gram-positive cocci susceptible to pirlimycin including staphylococcal organisms such as staphylococcus aureus, both penicillinase-positive and penicillinase-negative, and coagulase-negative staphylococci; streptococcal organisms including streptococcus agalactiae, streptococcus dysgalactiae and streptococcus uberis.